DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/2fa417/pfizer_incdetaile) has announced the addition of the "Pfizer Inc-Detailed Product Pipeline" company profile to their offering.
Pfizer Inc-Detailed Product Pipeline contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.
Scope of the reports
Pipeline Report provides the user with real detail on a company's pipeline.
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company's product pipeline and disease hub classification.
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company's deals and alliances and recent corporate news including key milestones.
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.
Key Topics Covered:
- Products by Phase of Development
- Products by Disease Hub Classification
- Products by Indication
Company Sales Figures
- Product Revenue
All Values in US Dollar (in millions)
- Revenue by Product Line
All Values in US Dollars (in millions)
- Company Announcements
- Deals & Alliances
- Intellectual Property
- Mergers & Acquisitions
- Product Updates
For more information visit http://www.researchandmarkets.com/research/2fa417/pfizer_incdetaile
Source: Life Science Analytics
Research and Markets
Laura Wood, Senior Manager,
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
KEYWORDS: United States North America
INDUSTRY KEYWORDS: Health Pharmaceutical